期刊文献+

糖尿病患者血尿转化生长因子β1变化及其意义 被引量:1

The change of serum and urinary transforming growth factor-beta-1 and their clinical significances in type 2 diabetics
下载PDF
导出
摘要 目的 观察2型糖尿病患者血、尿转化生长因子-β1 (TGF -β1 )变化,探讨TGF- β1与糖尿病肾病关系及其检测的临床意义。方法 对79例2型糖尿病患者和2 0例健康人,采用双抗体夹心酶联免疫吸附试验(ELASIA)同时检测血和尿中TGF β1浓度。结果 与正常对照比较,糖尿病患者血TGF β1 ( 4 5 .57±2 1 . 78vs 2 4 . 58±1 2 .6 1ng/ml)、尿TGF- β1 ( 6 1 . 6 8±35 .92vs 1 9 .89±1 3 0 6ng/mmol Cr)均增高,差异有显著意义,随肾病进展血、尿TGF- β1增高愈明显。在正常、微量和大量白蛋白尿糖尿病患者之间,血、尿TGF- β1水平存在显著差异;血TGF -β1、尿TGF -β1与2 4h尿白蛋白排泄率呈正相关(r =0 . 397,P <0 . 0 5;r =0 . 537,P <0 .0 5)。结论 糖尿病患者血、尿TGF -β1明显升高,并与糖尿病肾病进展一致。血、尿TGF- β1可以作为糖尿病肾病敏感的早期诊断指标之一。 Objective To observe the changes of serum and urinary transforming growth factor beta-1(TGF-β1) in type 2 diabetes and explore the clinical value of TGF-β1 in diabetic nephropathy. Methods Using enzyme-linked immunoadsorbent assay(ELISA), serum and urinary TGF-β1 levels were detected in 79 patients with type 2 diabetes and 20 controls. Results Serum and urinary TGF-β1 levels increased significantly in diabetic patients compared with the controls, and further rose as the nephropathy progressed. When compared with each other, there were significant differences in serum and urinary TGF-β1 levels between normol, micro-and macro-albuminuria diabetic groups( P <0.05). Serum and urinary TGF-β1 levels were positively correlated with urinary albumin excretion. Conclusion TGF-β1 may play an important role in pathogenesis and development of diabetic nephropathy. Serum and urinary TGF-β1 measurement may be one of the early markers in the diagnosis of diabetic nephropathy.
出处 《中国实验诊断学》 2005年第2期286-288,共3页 Chinese Journal of Laboratory Diagnosis
基金 安徽省自然科学基金资助项目 编号:01041181
关键词 糖尿病肾病 转化生长因子-Β1 diabetic nephropathy transforming growth factor-β1
  • 相关文献

参考文献8

  • 1Sharm K, Ziyadeh FN. Hyperglycemia and diabetic. The case for transforming growth factor-beta as a key mediator[J]. Diabetes, 1995,44:1130.
  • 2Sharm K, Jin Y, Guo J, et al. Neutralization of tgf-βby anti-tgfβantibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-nduced diabetic mice[J]. Diabetes, 1996,45:522.
  • 3Wogensen L, Nielsen CB, Hjorth P, et al. Under control of the Ren-1c proomoter, locally produced transforming growth factor-beta1 induces accumulalon of glomerular extnacellular matrix in transgenic nice[J]. Diabetes, 1999,48(1):182.
  • 4Hill C,flyvbjerg A, G ronback H et al. The renal expression of transforming growth factor isoforms and receptors in acute and chronic experimental diabetes in rats[J]. Endocrinology, 2000,141(3):1196.
  • 5Hellmich B, Secllner H, Schatz H, et al. Activation of transfonning growth factor-betal in diabetic kidney disease[J]. Metabolism, 2000,49(3) :353.
  • 6Ellis D, Forrest KY, Erbey J, et al. Urinary measurement of transforming growth factor- and type Ⅳ collagen as new markers of renal injury: application in diabetic nephro-pathy[J]. Clinical Chemistey, 1998,44(5):950.
  • 7Korpinen E, Akerblom HK, Teppo AM, et al. Urinary transforming growth factor-β1 and α1-microglobulin in children and adolescents with type 1 diabetes[J]. Diabetes Care, 2000,23:664.
  • 8Sato H, Iwano M, Akai Y, et al. Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy[J].AmJ Nephrol, 1998, 18(6):490.

同被引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部